Heart Disease Trial, Recruiting (NCT07058857)

Heart Disease Trial, Recruiting NCT07058857 Sponsor: Universitas Diponegoro Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07058857 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had a specific type of heart attack (called a STEMI) that started less than 12 hours ago
People who have agreed to take part in the study
People whose heart attack is not causing severe heart pump failure at the time they arrive for care (Killip class I or II — confirm with trial site if unsure what this means)
People whose blood pressure is at a safe level (systolic blood pressure above 90 mmHg and/or mean arterial pressure above 65 mmHg)
People whose heart is beating in a normal, regular rhythm (called sinus rhythm)

Who may not be able to join:

People with a history of a previous heart attack, stroke, heart failure with reduced pumping ability, a fully blocked coronary artery found on a previous heart scan, significant kidney disease (eGFR below 30), kidney dialysis, cancer, blood disorders, autoimmune conditions, or other ongoing chronic illnesses
People who have a permanent pacemaker fitted
People who currently have an active infection
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +6281316499074

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07058857

Sponsor: Universitas Diponegoro

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +6281316499074

More information: https://clinicaltrials.gov/study/NCT07058857

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had a specific type of heart attack (called a STEMI) that started less than 12 hours ago
People who have agreed to take part in the study
People whose heart attack is not causing severe heart pump failure at the time they arrive for care (Killip class I or II — confirm with trial site if unsure what this means)
People whose blood pressure is at a safe level (systolic blood pressure above 90 mmHg and/or mean arterial pressure above 65 mmHg)
People whose heart is beating in a normal, regular rhythm (called sinus rhythm)

Who may not be able to join:

People with a history of a previous heart attack, stroke, heart failure with reduced pumping ability, a fully blocked coronary artery found on a previous heart scan, significant kidney disease (eGFR below 30), kidney dialysis, cancer, blood disorders, autoimmune conditions, or other ongoing chronic illnesses
People who have a permanent pacemaker fitted
People who currently have an active infection
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universitas Diponegoro

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

1 September 2025

Where this trial is recruiting

🇮🇩 Indonesia

Primary endpoints

Left Ventricular Ejection Fraction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov